Literature DB >> 19165711

Electroencephalogram and flash visual evoked potentials for detecting periventricular leukomalacia.

H Kidokoro1, A Okumura, T Kato, F Hayakawa, J Natsume, T Kubota, K Watanabe, S Kojima.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the usefulness of a combination of electroencephalogram (EEG) and flash visual evoked potentials (FVEPs) for predicting periventricular leukomalacia (PVL) in the early days of life. STUDY
DESIGN: Eighty-six of 108 infants admitted to Anjo Kosei Hospital during 1998 through 2000 were enrolled in this study. All subjects underwent EEG and FVEP during the early neonatal period and were followed-up until 18 months of corrected age. EEG was performed once within 72 h after birth, every 1-2 weeks during the first month and every 2-4 weeks during the second month. FVEPs were recorded at least twice, at the first and the second week of life.
RESULTS: Of the 86 infants, 13 were diagnosed as having PVL. Among them, EEG abnormalities were observed in 11 infants and FVEP abnormalities in 10. The sensitivity and specificity of EEG were 0.85 and 0.95, respectively. The sensitivity and specificity of FVEPs were 0.77 and 0.96, respectively. All except one (92%) infant with PVL had EEG and/or FVEP abnormalities.
CONCLUSIONS: The combination of EEG and FVEPs can increase the sensitivity, but reduces the specificity to identify infants with PVL. The combination can makes up for the shortcomings of each method.

Entities:  

Mesh:

Year:  2009        PMID: 19165711     DOI: 10.1055/s-0028-1105902

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  2 in total

1.  Electroencephalography may provide insight into timing of premature brain injury.

Authors:  Joseph J Volpe
Journal:  Pediatrics       Date:  2009-08-10       Impact factor: 7.124

2.  Flash visual evoked potentials in patients with periventricular leucomalacia in children less than 1 year of age.

Authors:  Jitendra Jethani; Monika Jethani
Journal:  Indian J Ophthalmol       Date:  2013-11       Impact factor: 1.848

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.